Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis
暂无分享,去创建一个
Augusto Silva | Rosa Luna | R. Luna | Augusto Silva | J. A. Bernal | F. Ramos-Morales | F. Romero | José Antonio Pintor-Toro | M. Tortolero | Francisco Ramos-Morales | Juan A. Bernal | Águeda Espina | Icíar Lázaro | Francisco Romero | Carmen Arias | María Tortolero | José A. Pintor-Toro | I. Lázaro | Á. Espina | C. Arias
[1] E. Lam,et al. Physical and functional interactions between p53 and cell cycle co‐operating transcription factors, E2F1 and DP1. , 1995, The EMBO journal.
[2] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[3] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[4] S. Sukumar,et al. Compromised HOXA5 function can limit p53 expression in human breast tumours , 2000, Nature.
[5] H R Hoogenboom,et al. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. , 1991, Nucleic acids research.
[6] D. Banker,et al. Mitochondria and apoptosis: new therapeutic targets. , 2002, Advances in cancer research.
[7] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[8] K. Kinzler,et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. , 1999, The Journal of clinical investigation.
[9] R. Luna,et al. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product , 2000, Oncogene.
[10] F. Ramos-Morales,et al. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG , 1998, Oncogene.
[11] J. Roth,et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression , 1995, Molecular and cellular biology.
[12] S. Melmed,et al. Expression of pituitary-tumour transforming gene in colorectal tumours , 2000, The Lancet.
[13] J. A. Bernal,et al. Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. , 2001, Nucleic acids research.
[14] L. Pei. Identification of c-myc as a Down-stream Target for Pituitary Tumor-transforming Gene* , 2001, The Journal of Biological Chemistry.
[15] Michael R. Speicher,et al. Securin Is Required for Chromosomal Stability in Human Cells , 2001, Cell.
[16] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[17] L. Loeb,et al. Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.
[18] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[19] M. Ewen,et al. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. , 1993, Genes & development.
[20] K. Vousden,et al. Minireviewp 53 : Death Star able to induce the defensive p 53 response to oncogene , 2000 .
[21] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[22] F. Ramos-Morales,et al. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias , 1999, Oncogene.
[23] P. Friedman,et al. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. , 1992, Genes & development.
[24] A. Valentini,et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). , 1999, Molecular endocrinology.
[25] S. Lowe,et al. Apoptosis and therapy , 1999, The Journal of pathology.
[26] W. Gerald,et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.
[27] S. Melmed,et al. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. , 2001, Molecular endocrinology.
[28] Bert Vogelstein,et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.
[29] M. Kirschner,et al. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. , 1999, Science.
[30] K. Kinzler,et al. 14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .
[31] Pumin Zhang,et al. Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts , 2001, Current Biology.